• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Plasma binding of drugs in chronic renal failure].

作者信息

Riant P, Barre J, Albengres E, Lemaire M, Tillement J P

出版信息

Nephrologie. 1986;7(3):89-93.

PMID:3774085
Abstract

As in many pathological states, changes in the plasma protein binding of drugs are observed in uremia. Renal failure reduces the fraction of many acidic drugs bound to serum albumin. This decreased binding is due to many factors: variations of protein concentrations, structural changes of proteins, competitive displacers in plasma of chronic uremic patients. When the margin between pharmacological and toxic doses is narrow, drug monitoring by measurement of plasma free drug concentrations seems necessary to adjust the dosage regimen in uremic patients.

摘要

相似文献

1
[Plasma binding of drugs in chronic renal failure].
Nephrologie. 1986;7(3):89-93.
2
Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.口服吸附剂AST-120对尿毒症患者色氨酸代谢的影响。
Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S38-41. doi: 10.1053/ajkd.2003.50082.
3
Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.
Clin Nephrol. 1976 Sep;6(3):388-93.
4
[Factors of variation in plasma protein binding of drugs in patients with chronic renal failure].[慢性肾功能衰竭患者药物血浆蛋白结合的变异因素]
Therapie. 1987 Oct-Dec;42(6):507-10.
5
In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.使用电位离子探针技术对双氯芬酸和尿毒症毒素与血清白蛋白及人血浆的竞争性结合进行的体外研究。
J Pharm Pharmacol. 2006 Nov;58(11):1467-74. doi: 10.1211/jpp.58.11.0007.
6
Differential effects of hepatic cirrhosis on the plasma protein binding of drugs.
Int J Clin Pharmacol Res. 1984;4(5):327-33.
7
Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.药物与人血清白蛋白的结合:XI. 用固定在微粒中的白蛋白研究三个结合位点的特异性。
Mol Pharmacol. 1979 Nov;16(3):767-77.
8
[Characteristics of the pharmacokinetics of drugs in renal failure].[肾衰竭时药物的药代动力学特征]
Farmakol Toksikol. 1985 Sep-Oct;48(5):109-13.
9
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
10
Plasma protein binding of drugs and adjustment of their dosing regimen in patients with chronic renal failure.药物的血浆蛋白结合与慢性肾衰竭患者给药方案的调整
Int J Clin Pharmacol Ther Toxicol. 1987 Sep;25(9):476-8.